Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Reduced efficacy of rosuvastatin by St. John's Wort.

Gordon RY, Becker DJ, Rader DJ.

Am J Med. 2009 Feb;122(2):e1-2. doi: 10.1016/j.amjmed.2008.09.033. No abstract available.

PMID:
19185075
2.
3.

Treatment and prevention of dyslipidemia with rosuvastatin (Crestor).

Leonard KA.

Nurse Pract. 2004 May;29(5):11-5. Review. No abstract available.

PMID:
15167530
4.

Safety and efficacy of St. John's wort (hypericum) during pregnancy and lactation.

Dugoua JJ, Mills E, Perri D, Koren G.

Can J Clin Pharmacol. 2006 Fall;13(3):e268-76. Review.

PMID:
17085775
5.

Pharmacokinetic interactions of drugs with St John's wort.

Zhou S, Chan E, Pan SQ, Huang M, Lee EJ.

J Psychopharmacol. 2004 Jun;18(2):262-76. Review.

PMID:
15260917
6.

Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia.

Tzeng TB, Schneck DW, Birmingham BK, Mitchell PD, Zhang H, Martin PD, Kung LP.

Curr Med Res Opin. 2008 Sep;24(9):2575-85. doi: 10.1185/03007990802312807 .

PMID:
18674408
7.

Concern still warranted: medication burden and persistence with lipid-lowering drugs.

Polinski JM, Gagne JJ.

Am J Manag Care. 2009 Jan;15(1):74-5. No abstract available.

8.

Effects of St. John's wort supplementation on ibuprofen pharmacokinetics.

Bell EC, Ravis WR, Lloyd KB, Stokes TJ.

Ann Pharmacother. 2007 Feb;41(2):229-34.

PMID:
17284505
9.

Exaggerated benefits of rosuvastatin compared with other statins.

Qizilbash N.

Pharmacoepidemiol Drug Saf. 2009 May;18(5):425-6. doi: 10.1002/pds.1728. No abstract available.

PMID:
19382149
10.

Statins: how far have we come? A review of rosuvastatin.

Olsson A.

Int J Clin Pract Suppl. 2003 Oct;(137):15-25. Review. No abstract available.

PMID:
14649698
11.

CORONA--rosuvastatin in older patients with systolic heart failure.

Jackson G.

Int J Clin Pract. 2008 Jan;62(1):1. doi: 10.1111/j.1742-1241.2007.01663.x. No abstract available.

PMID:
18173807
12.

St John's wort and depression: slight efficacy at best, many drug interactions.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):187-92.

PMID:
15499702
13.

Herb-drug interactions. St. John's wort and prescription medications.

Bressler R.

Geriatrics. 2005 Jul;60(7):21-3. Review. No abstract available.

PMID:
16026178
14.

Cosmic effect of rosuvastatin in COSMOS.

Adachi T, Ohsuzu F.

Circ J. 2009 Nov;73(11):2015-6. No abstract available.

15.

[Less vascular risk with rosuvastatin in elevated CRP].

Bredie B.

Ned Tijdschr Geneeskd. 2009 Feb 7;153(6):245. Dutch. No abstract available.

PMID:
19271446
16.

Is the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA) the answer to the cholesterol paradox in heart failure?

Velavan P, Loh PH, Clark A, Cleland JG.

Congest Heart Fail. 2008 Jan-Feb;14(1):55. No abstract available.

PMID:
18256572
17.

The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate.

Smith P, Bullock JM, Booker BM, Haas CE, Berenson CS, Jusko WJ.

Pharmacotherapy. 2004 Nov;24(11):1508-14. Erratum in: Pharmacotherapy. 2004 Dec;24(12):1837.

PMID:
15537555
18.

Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.

de Kruif MD, Limper M, Hansen HR, de Ruiter J, Spek CA, van Gorp EC, ten Berge IJ, Rowshani AT, ten Cate H, Meesters EW.

Ann Rheum Dis. 2009 Oct;68(10):1654. doi: 10.1136/ard.2009.109405. No abstract available.

PMID:
19748921
19.

Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).

Serebruany VL.

Am J Cardiol. 2008 Jun 15;101(12):1808-9. doi: 10.1016/j.amjcard.2008.02.084. No abstract available.

PMID:
18549865
20.

Pharmacokinetic interactions between clopidogrel and rosuvastatin: effects on vascular protection in subjects with coronary heart disease.

Pinheiro LF, França CN, Izar MC, Barbosa SP, Bianco HT, Kasmas SH, Mendes GD, Povoa RM, Fonseca FA.

Int J Cardiol. 2012 Jun 28;158(1):125-9. doi: 10.1016/j.ijcard.2012.04.051. No abstract available.

Supplemental Content

Support Center